Contains fulltext : 47454.pdf (publisher's version ) (Open Access)PURPOSE: To evaluate the role of the optineurin gene (OPTN) in Indian primary open angle glaucoma (POAG) patients from different parts of the country. METHODS: Two hundred patients with POAG and 200 ethnically matched normal controls were recruited from various parts of India for the study. The entire coding region of OPTN along with the intron-exon boundaries were screened by PCR and single strand conformation polymorphism (SSCP) followed by direct sequencing. A rapid screening method was developed for some of the observed variants by denaturing high performance liquid chromatography (dHPLC). Four variants were also confirmed by digesting the amplicon with ...
Contains fulltext : 88359.pdf (publisher's version ) (Open Access)PURPOSE: To inve...
Glaucoma represents a group of optic neuropathies with different genetic basis. In India, ~1.5 milli...
Glaucoma, a heterogeneous group of neurodegenerative disorders of the eye, affects about 67 million ...
Contains fulltext : 47799.pdf (publisher's version ) (Open Access)PURPOSE: Myocili...
PURPOSE: To assess the influence of optineurin in the more common high-tension, primary open-angle...
PURPOSE: To evaluate the extent to which mutations in the optineurin (OPTN) glaucoma gene play a rol...
PURPOSE. The optineurin gene (OPTN) is the second gene besides MYOC in which mutations have been ide...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Purpose: To verify the frequencies of T...
Purpose: To evaluate the individual and interactive effects of polymorphisms in the myocilin (MYOC),...
PURPOSE: To investigate the expression level of the optineurin gene (OPTN) in the blood of primary o...
7 páginas, 2 figuras, 5 tablas.-- et al.[Purpose]: To investigate the clinical features of subjects ...
Contains fulltext : 52806theelen.pdf (publisher's version ) (Open Access)PURPOSE: ...
Glaucoma, the second leading cause of blindness, is a heterogeneous group of optic neuropathies hav...
Purpose: Glaucoma is the second leading cause of blindness. In India, ~1.5 million people are blind ...
Contains fulltext : 138859.pdf (publisher's version ) (Open Access)PURPOSE: Despit...
Contains fulltext : 88359.pdf (publisher's version ) (Open Access)PURPOSE: To inve...
Glaucoma represents a group of optic neuropathies with different genetic basis. In India, ~1.5 milli...
Glaucoma, a heterogeneous group of neurodegenerative disorders of the eye, affects about 67 million ...
Contains fulltext : 47799.pdf (publisher's version ) (Open Access)PURPOSE: Myocili...
PURPOSE: To assess the influence of optineurin in the more common high-tension, primary open-angle...
PURPOSE: To evaluate the extent to which mutations in the optineurin (OPTN) glaucoma gene play a rol...
PURPOSE. The optineurin gene (OPTN) is the second gene besides MYOC in which mutations have been ide...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Purpose: To verify the frequencies of T...
Purpose: To evaluate the individual and interactive effects of polymorphisms in the myocilin (MYOC),...
PURPOSE: To investigate the expression level of the optineurin gene (OPTN) in the blood of primary o...
7 páginas, 2 figuras, 5 tablas.-- et al.[Purpose]: To investigate the clinical features of subjects ...
Contains fulltext : 52806theelen.pdf (publisher's version ) (Open Access)PURPOSE: ...
Glaucoma, the second leading cause of blindness, is a heterogeneous group of optic neuropathies hav...
Purpose: Glaucoma is the second leading cause of blindness. In India, ~1.5 million people are blind ...
Contains fulltext : 138859.pdf (publisher's version ) (Open Access)PURPOSE: Despit...
Contains fulltext : 88359.pdf (publisher's version ) (Open Access)PURPOSE: To inve...
Glaucoma represents a group of optic neuropathies with different genetic basis. In India, ~1.5 milli...
Glaucoma, a heterogeneous group of neurodegenerative disorders of the eye, affects about 67 million ...